EC Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Leslie Lu

İcra Kurulu Başkanı

HK$4.8m

Toplam tazminat

CEO maaş yüzdesi	99.6%
CEO görev süresi	1.1yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	2.4yrs
Yönetim Kurulu ortalama görev süresi	8.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Leslie Lu'un ücretlendirmesi EC Healthcare'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	-HK$12m
Jun 30 2024	n/a	n/a	-HK$15m
Mar 31 2024	HK$5m	HK$5m	-HK$19m
Dec 31 2023	n/a	n/a	-HK$11m
Sep 30 2023	n/a	n/a	-HK$4m
Jun 30 2023	n/a	n/a	HK$33m
Mar 31 2023	HK$21m	HK$4m	HK$70m
Dec 31 2022	n/a	n/a	HK$93m
Sep 30 2022	n/a	n/a	HK$117m
Jun 30 2022	n/a	n/a	HK$157m
Mar 31 2022	HK$13m	HK$2m	HK$198m

Tazminat ve Piyasa: Leslie 'nin toplam tazminatı ($USD 620.26K ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 467.65K ).

Tazminat ve Kazançlar: Leslie 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Leslie Lu (44 yo)

1.1yrs

Görev süresi

HK$4,818,000

Tazminat

Mr. Lyn Wade Lu, also known as Leslie, served as Co-Chief Executive Officer & Executive Director at EC Healthcare since August 23, 2021 until November 1, 2023. He serves as Chief Executive Officer at EC He...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Chi Fai Tang	Founder & Executive Chairman	9.1yrs	HK$1.24m	60.93% € 61.7m
Lyn Wade Lu	Chief Executive Officer & Executive Director	1.1yrs	HK$4.82m	Veri yok
Heung Wing Lee	CFO & Executive Director	5.4yrs	HK$3.77m	0.057% € 58.1k
Tai Cheung Wong	Chief Operating Officer	2.4yrs	Veri yok	Veri yok
Kelly Tsang	Associate Director of Accounting	no data	Veri yok	Veri yok
Kin Keung Chan	Chief Public Affairs Officer & Chief Dental Officer	2.4yrs	Veri yok	Veri yok
Katy Ip	Sales Director	no data	Veri yok	Veri yok
Chun Pu Chu	Chief Business Officer	4.3yrs	Veri yok	Veri yok
Chun Yu Chan	Chief Talent Officer	2.4yrs	Veri yok	Veri yok
Julie Chow	Chief Proposition Officer of Healthcare	1.9yrs	Veri yok	Veri yok
Chun Pong Siu	Company Secretary	7.3yrs	Veri yok	Veri yok

2.4yrs

Ortalama Görev Süresi

45yo

Ortalama Yaş

Deneyimli Yönetim: 1UM0 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.4 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Chi Fai Tang	Founder & Executive Chairman	9.1yrs	HK$1.24m	60.93% € 61.7m
Lyn Wade Lu	Chief Executive Officer & Executive Director	3.3yrs	HK$4.82m	Veri yok
Heung Wing Lee	CFO & Executive Director	4.9yrs	HK$3.77m	0.057% € 58.1k
Ching Nam Ma	Independent Non-Executive Director	8.8yrs	HK$240.00k	0.025% € 25.6k
Andrew Look	Independent Non-Executive Director	8.8yrs	HK$220.00k	Veri yok
Kun Shing Luk	Non Executive Director	9.3yrs	HK$126.00k	0.24% € 241.2k
Tsun Au	Independent Non-Executive Director	2.3yrs	HK$120.00k	Veri yok

8.8yrs

Ortalama Görev Süresi

44yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 1UM0 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.8 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2024/12/25 04:16
Gün Sonu Hisse Fiyatı	2024/12/23 00:00
Kazançlar	2024/09/30
Yıllık Kazançlar	2024/03/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

EC Healthcare 10 Bu analistlerden 1, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Tingting Li	BOCI Research Ltd.
Zhuonan Xu	China International Capital Corporation Limited
null null	China International Capital Corporation Limited

EC Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Less than half of directors are independent

EC Healthcare, Annual General Meeting, Aug 23, 2024

EC Healthcare Announces the Resignation of Mr. Wong Chi Cheung as Executive Director and Chief Digital Officer of the Company with Effect from 31 December 2023

EC Healthcare Announces Executive Changes

EC Healthcare, Annual General Meeting, Aug 23, 2023

Less than half of directors are independent

Recent updates

EC Healthcare Declares Ordinary Interim (Semi-Annual) Dividend for the Six Months Ended 30 September 2024, Payable on 24 January 2025

New minor risk - Market cap size

EC Healthcare to Report First Half, 2025 Results on Nov 28, 2024

Ec Healthcare Provides Sales Expectations for Six Months Ended 30 September 2024

Less than half of directors are independent

EC Healthcare Provides Group Earnings Guidance for the Period from 1 April 2024 to 30 June 2024

Full year 2024 earnings released: HK$0.016 loss per share (vs HK$0.059 profit in FY 2023)

Now 22% undervalued after recent price drop

Full year 2024 earnings released: HK$0.016 loss per share (vs HK$0.059 profit in FY 2023)

EC Healthcare, Annual General Meeting, Aug 23, 2024

EC Healthcare to Report Fiscal Year 2024 Results on Jun 27, 2024

An undisclosed buyer entered into an agreement to acquire additional 51% stake in Preeminent Medical Centre Limited from EC Healthcare (SEHK:2138) for HKD 80.2 million.

Now 26% overvalued after recent price rise

Now 29% overvalued

Now 23% overvalued

EC Healthcare (SEHK:2138) entered into sale and purchase agreement to acquire 6.49% stake in Pangenia Inc from Sharp Point Consultant Limited for HKD 17.4 million.

EC Healthcare Announces the Resignation of Mr. Wong Chi Cheung as Executive Director and Chief Digital Officer of the Company with Effect from 31 December 2023

First half 2024 earnings released: EPS: HK$0.006 (vs HK$0.068 in 1H 2023)

EC Healthcare Declares an Interim Dividend for the Six Months Ended 30 September 2023, Payable on January 19, 2024

Ec Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2023

EC Healthcare to Report First Half, 2024 Results on Nov 30, 2023

EC Healthcare Announces Executive Changes

Ec Healthcare Approves Dividend for the Year Ended 31 March 2023, Payment Date Is 18 September 2023

Upcoming dividend of HK$0.042 per share at 2.6% yield

Ec Healthcare Approves Final Dividend for the Year Ended 31 March 2023

New major risk - Share price stability

Full year 2023 earnings released: EPS: HK$0.059 (vs HK$0.17 in FY 2022)

Full year 2023 earnings released: EPS: HK$0.059 (vs HK$0.17 in FY 2022)

EC Healthcare, Annual General Meeting, Aug 23, 2023

EC Healthcare Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023

EC Healthcare to Report Fiscal Year 2023 Final Results on Jun 23, 2023

Upcoming dividend of HK$0.058 per share

First half 2023 earnings released

EC Healthcare Announces Interim Dividend for the Six Months Ended 30 September 2022, Payable on 20 January 2023

Less than half of directors are independent

EC Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2022

EC Healthcare to Report Q2, 2023 Results on Nov 24, 2022

Chairman & Co-CEO recently bought €75k worth of stock

EC Healthcare Announces Executive Changes

Upcoming dividend of HK$0.042 per share

EC Healthcare Approves Final Dividend for the Year Ended 31 March 2022, Payable on 20 September 2022

Full year 2022 earnings released: EPS: HK$0.17 (vs HK$0.19 in FY 2021)

EC Healthcare Proposes Final Dividend for the Year Ended 31 March 2022

Full year 2022 earnings released: EPS: HK$0.17 (vs HK$0.19 in FY 2021)

EC Healthcare, Annual General Meeting, Aug 23, 2022

EC Healthcare to Report Fiscal Year 2022 Final Results on Jun 23, 2022

EC Healthcare (SEHK:2138) entered into agreement to acquire 75% stake in Mobile Medical International Holdings Limited from certain existing shareholders for HKD 41.25 million.

Less than half of directors are independent

EC Healthcare Provides Sales Guidance for the Year Ended 31 March, 2022

EC Healthcare (SEHK:2138) completed the acquisition of Excellent Power Investments Limited from GenRx Holdings Limited.

Chairman & Co-CEO recently bought €60k worth of stock

EC Healthcare (SEHK:2138) entered into an agreement to acquire Excellent Power Investments Limited from GenRx Holdings Limited for HKD 68 million.

Chairman & Co-CEO recently bought €561k worth of stock

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of HK$0.10 per share

First half 2022 earnings: Revenues and EPS in line with analyst expectations

EC Healthcare (SEHK:2138) agreed to acquire a 55% stake in Bayley & Jackson Dental Surgeons Limited for approximately HKD 130 million.

Investor sentiment improved over the past week

COO & Executive Director Gabriel Lee has left the company

Upcoming dividend of HK$0.13 per share

Full year 2021 earnings released: EPS HK$0.19 (vs HK$0.29 in FY 2020)

COO & Executive Director recently sold €1.9m worth of stock

EC Healthcare (SEHK:2138) entered into an agreement to acquire 51% equity interests in King Equity, Eternal Harvest, HKVIC and Crown Leader from Dr. Tiong and Dr. Tan for HKD 66 million.

EC Healthcare has completed a Follow-on Equity Offering in the amount of HKD 231.1608 million.

Union Medical Healthcare Limited Provides Revenue Guidance for the Year Ended March 31, 2021

Union Medical Healthcare Limited (SEHK:2138) signed an agreement to acquire an additional 45% stake in Young Aesthetics Medical Limited from Arnold Jonathan Che Teng Young and Tan Ho Yin, Timothy for HKD 9.8 million.

New 90-day high: €0.84

COO & Executive Director recently sold €29k worth of stock

COO & Executive Director recently sold €67k worth of stock